Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression-Reference-Cited by-同舟云学术

Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression

Published:2009-10 Issue:10 Volume:17 Page:1779-1787
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ahmed Nabil,Salsman Vita S,Yvon Eric,Louis Chrystal U,Perlaky Laszlo,Wels Winfried S,Dishop Meghan K,Kleinerman Eugenie E,Pule Martin,Rooney Cliona M,Heslop Helen E,Gottschalk Stephen

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference46 articles.

1. Osteosarcoma;Link,2006

2. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy;Bacci;Acta Oncol,2005

3. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors;Flint;Vet Pathol,2004

4. ERBB2 in pediatric cancer: innocent until proven guilty;Gilbertson;Oncologist,2005

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances on immunotherapy for osteosarcoma;Molecular Cancer;2024-09-09

2. Biomaterials‐Boosted Immunotherapy for Osteosarcoma;Advanced Healthcare Materials;2024-07-05

3. Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial;Nature Cancer;2024-04-24

4. Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research;Frontiers in Oncology;2024-03-12

5. A dual-luciferase bioluminescence system for the assessment of cellular therapies;Molecular Therapy: Oncology;2024-03